|
US3689514A
(en)
*
|
1969-05-21 |
1972-09-05 |
Schlueter Edelfett |
Suppository vehicle and process of making same
|
|
US4211777A
(en)
*
|
1977-11-25 |
1980-07-08 |
Fisons Limited |
Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
|
|
US4298595A
(en)
*
|
1978-12-20 |
1981-11-03 |
Dynapol |
Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
|
|
US4374932A
(en)
*
|
1981-06-08 |
1983-02-22 |
G. D. Searle & Co. |
5-ASA Drug delivery system
|
|
DE3151196A1
(de)
*
|
1981-12-23 |
1983-06-30 |
Kurt Heinz Prof. Dr. 7800 Freiburg Bauer |
Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
|
|
JPH0816051B2
(ja)
*
|
1988-12-07 |
1996-02-21 |
エスエス製薬株式会社 |
徐放性坐剤
|
|
US5629012A
(en)
*
|
1991-06-17 |
1997-05-13 |
Farmaceutisk Laboratorium Ferring A/S |
Process for producing suppositories by compression and suppositories obtained by the process
|
|
GB9201857D0
(en)
*
|
1992-01-29 |
1992-03-18 |
Smithkline Beecham Plc |
Novel compound
|
|
US5389375A
(en)
*
|
1993-05-21 |
1995-02-14 |
University Of Mississippi |
Stable suppository formulations effecting bioavailability of Δ9 -thc
|
|
DK66493D0
(da)
*
|
1993-06-08 |
1993-06-08 |
Ferring A S |
Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
|
|
CA2231176C
(en)
*
|
1995-09-07 |
2008-04-01 |
Taisho Pharmaceutical Co., Ltd. |
Long active composition for rectal administration
|
|
JPH09323934A
(ja)
*
|
1996-05-31 |
1997-12-16 |
Kanebo Ltd |
保存安定性の改善された坐剤
|
|
CA2285923C
(en)
|
1997-04-01 |
2013-03-12 |
Thomas Julius Borody |
Methods and compositions for treating inflammatory bowel disease
|
|
WO1999016454A1
(en)
*
|
1997-09-26 |
1999-04-08 |
Medeva Europe Limited |
Pharmaceutical composition for the treatment of inflammatory bowel disease
|
|
CA2305761A1
(en)
*
|
1997-10-08 |
1999-04-15 |
Taisho Pharmaceutical Co., Ltd. |
Composition for suppositories
|
|
US6326364B1
(en)
*
|
1999-02-08 |
2001-12-04 |
Cedars-Sinai Medical Center |
Use of 5-aminosalicylates as antimicrobial agents
|
|
US6610674B1
(en)
*
|
1999-09-28 |
2003-08-26 |
University Of Pennsylvania |
Method of treating inflammatory conditions with progesterone analogs
|
|
US6720001B2
(en)
*
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
US20020037855A1
(en)
*
|
2000-05-05 |
2002-03-28 |
Fritz Stanislaus |
Stabilized medicament containing cysteinyl derivatives
|
|
AU2001285311B2
(en)
*
|
2000-08-29 |
2005-09-15 |
Biocon, Ltd |
Immunoregulatory compounds, derivatives thereof and their use
|
|
JP2006501242A
(ja)
*
|
2002-08-23 |
2006-01-12 |
ザイモジェネティクス， インク． |
炎症性腸疾患の治療方法
|
|
US7312243B1
(en)
*
|
2003-08-29 |
2007-12-25 |
Jay Pravda |
Materials and methods for treatment of gastrointestinal disorders
|
|
US7825106B2
(en)
*
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
|
CA2553775A1
(en)
*
|
2004-01-20 |
2005-08-11 |
Richard F. Harty |
Compositions and methods of treatment for inflammatory diseases
|
|
CA2565993C
(en)
*
|
2004-05-27 |
2011-08-16 |
Antibe Therapeutics Inc. |
Salt of 4-or 5- aminosalicylic acid
|
|
CZ296169B6
(cs)
*
|
2004-09-08 |
2006-01-11 |
Pliva - Lachema A. S. |
Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
|
|
CA2581775A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Sigmoid Biotechnologies Limited |
Dihydropyrimidine microcapsule - formulations
|
|
US7250445B1
(en)
*
|
2005-01-14 |
2007-07-31 |
Ehrenpreis Eli D |
Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
|
|
US8921344B2
(en)
*
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
EP1993540A4
(en)
*
|
2006-03-07 |
2010-06-09 |
Combinatorx Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
|
|
EP2034816A1
(en)
*
|
2006-04-05 |
2009-03-18 |
Oklahoma Medical Research Foundation |
O-glycans in the treatment of inflammatory bowel disease and cancers
|
|
EP2015639A4
(en)
*
|
2006-05-01 |
2009-11-25 |
Napo Pharmaceuticals Inc |
METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
|
|
US20070254050A1
(en)
*
|
2006-05-01 |
2007-11-01 |
Quart Barry D |
Method for treatment of diarrhea-predominant irritable bowel syndrome
|
|
WO2008031013A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Gene Logic Inc. |
Method for treating inflammatory diseases of the digestive tract
|
|
US8436051B2
(en)
|
2007-06-08 |
2013-05-07 |
Aptalis Pharma Canada Inc. |
Mesalamine suppository
|
|
US8217083B2
(en)
*
|
2007-06-08 |
2012-07-10 |
Aptalis Pharma Canada Inc. |
Mesalamine suppository
|
|
US7541384B2
(en)
*
|
2007-06-08 |
2009-06-02 |
Axcan Pharma Inc. |
Mesalamine suppository
|